Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RCKT
RCKT logo

RCKT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

RCKT News

Rocket Pharmaceuticals Receives Accelerated FDA Approval for Kresladi

Mar 30 2026NASDAQ.COM

Rocket Pharmaceuticals Secures FDA Approval for KRESLADI

Mar 29 2026Yahoo Finance

RCKT Shares Plummet Following Gene Therapy Approval as Wall Street Overlooks Decline

Mar 27 2026stocktwits

ROCKET PHARMA EXECUTIVE ANNOUNCES ACTIVE TALKS WITH EXTERNAL PARTIES ABOUT SELLING THE PRIORITY REVIEW VOUCHER

Mar 27 2026moomoo

Rocket Pharmaceuticals Stock Rises 10.2% in Premarket Trading Following FDA Approval of Therapy for Severe Childhood Disorder

Mar 27 2026moomoo

Rocket Pharmaceuticals Secures Accelerated Approval for KRESLADI Gene Therapy

Mar 27 2026NASDAQ.COM

FDA Approves First Gene Therapy for Children with Severe LAD-I

Mar 27 2026Newsfilter

Rocket Pharmaceuticals' Kresladi Receives FDA Approval

Mar 27 2026seekingalpha

RCKT Events

No data

No data

RCKT Monitor News

Rocket Pharmaceuticals Receives FDA Approval for KRESLADI Gene Therapy

Mar 27 2026

RCKT Earnings Analysis

No Data

No Data

People Also Watch